This inventor holds 1 USPTO granted patent. Top assignee: Asahi Glass Company, Limited. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Innovations by Atsushi Isoai in Cancer Research
Introduction
Atsushi Isoai is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of cancer research through his innovative work on tumor cell invasion-inhibiting peptides. His research aims to develop effective treatments for cancer metastasis, which is a critical area of study in oncology.
Latest Patents
Atsushi Isoai holds a patent for "Tumor cell invasion-inhibiting peptides, peptide complexes and cancer." This invention involves a peptide consisting of 5 to 20 amino acid residues that exhibit tumor cell invasion-inhibiting activities. The patent outlines a cancer metastasis inhibitor that includes this peptide as an active ingredient. Additionally, the invention describes a peptide complex that combines the tumor cell invasion-inhibiting peptide with a polymer derived from a vital body, such as albumin or globulin. This complex also serves as a cancer metastasis inhibitor.
Career Highlights
Atsushi Isoai is affiliated with Asahi Glass Company, Limited, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential to improve therapeutic strategies against cancer metastasis. With a focus on innovative peptide technologies, he is contributing to the development of new medical solutions.
Collaborations
Atsushi collaborates with esteemed colleagues, including Yuko Hama and Hiromichi Kumagai. Their combined expertise enhances the research efforts in the field of cancer treatment.
Conclusion
Atsushi Isoai's innovative work in developing tumor cell invasion-inhibiting peptides represents a significant advancement in cancer research. His contributions have the potential to lead to more effective treatments for cancer patients.